全国统一24小时服务热线:400-0000-889400-0000-889  / 13999887799

热门新闻

当前位置:主页 > 热门新闻 >

Occlutech Initiates Non-Infringement Proceedings and Files f

发布时间:2018-10-19 08:51 作者:AG88 来源:AG 点击: 字号:

JENA, Germany, Aug. 20 /Xinhua-PRNewswire/ -- 大发体育Occlutech GmbH, the leading European manufacturer of cardiac occlusion devices such as ASD, PFO and LAA occluders today announced that it has initiated invalidation proceedings against AGA's European patent in the U.K. Most of the broader claims interpreted into this patent by AGA Medical were not accepted by the examiners of the European Patent Office in the original patent approval process due to the existence of prior art. This creates a significant and justified basis for Occlutech to file for invalidation.

In addition, Occlutech is asking the U.K. court to rule that their devices are outside the claims of AGA's patent, on the grounds of substantial differences between the patent and the configuration of the Occlutech devices. No date has yet been fixed for the hearing, but Occlutech will be seeking an early ruling on these issues.

Occlutech's CEO Robert Moszner says, "We see a substantial chance that AGA's European patent will be invalidated by this and as a result of AGA's own actions and argumentation with the European Patent Office."

He continues, "Occlutech's technology base is very different from AGA's where we do an individual braiding of each device. Our unique technology and methods are superior and very different from anything else on the market and we are eager to have the non-infringement confirmed in court in the U.K. as early as possible."

Occlusion devices are used to treat structural heart disease, including structural heart defects and abnormalities, such as Atrial Septal Defects (ASD), or Patent Foramen Ovale (PFO), in a minimally invasive, non-surgical way. The market for these devices, and the PFO occluders in particular, are expected to expand significantly over the next few years.

本文源自: 环亚娱乐

相关文章Related Articles

如果您觉得本站还不错,就请分享给身边的好友吧


分享成功还有机会获得精美礼品哦